#GoldmanSachsBullishOnCXMT

#GoldmanSachsBullishOnCXMT
CXMT is becoming one of the most important names in China’s semiconductor push. Goldman Sachs has initiated coverage on ChangXin Memory Technologies with a Buy rating and a CNY 129 price target, but the more interesting part of the report is the reasoning behind that target: Goldman sees a combination of expanding DRAM capacity, stronger domestic substitution and growing AI-memory demand creating a multi-year earnings opportunity.

Capacity expansion is the biggest part of the thesis. Goldman expects CXMT’s monthly wafer capacity to rise from roughly 270,000 units in 2026 to 447,000 in 2028 and 665,000 by 2030. That is more than a 2x increase in four years. The important distinction is that this is future production capacity, not current market share. Goldman estimates that the expanded supply could eventually represent around 50% of China’s DRAM demand by 2028, assuming investment, yields and customer validation progress as expected.

The industry backdrop is unusually supportive. Counterpoint says global DRAM demand continues to exceed supply as AI infrastructure expands, while conventional DRAM prices have already risen sharply. CXMT was also the fastest-growing DRAM supplier in its Q2 2026 assessment, with revenue growth of roughly 716% year over year. That combination of strong demand and rapidly expanding CXMT shipments is exactly the type of environment where additional capacity can translate into significant revenue growth.

But capacity alone does not justify CNY 129. The market ultimately needs to see that additional wafers become profitable products. Yield rates, utilization, product mix, pricing and manufacturing efficiency will determine how much of CXMT’s future capacity actually converts into earnings. This is why Goldman’s valuation is based on much more than volume growth: its CNY 129 target assumes substantial improvement in profitability as CXMT moves further up the technology curve.

HBM is the high-upside part of the story. Goldman expects HBM-related revenue to increase from around 2% of CXMT revenue in 2026 to 27% by 2030. That would materially change the company's product mix because AI accelerators require high-bandwidth memory with much greater value per unit than conventional DRAM. The catch is that HBM is technically demanding, so customer qualification, yields and production scale will be critical before investors can treat this forecast as a certainty.

There is already evidence that CXMT is gaining global relevance. Reuters identified CXMT as the world's fourth-largest DRAM maker in 2025, with approximately 7.7% market share, while its July IPO raised about CNY 57.9 billion. That capital gives the company significant resources to fund capacity expansion and technology development. The IPO itself was extraordinary, with shares closing dramatically above the CNY 8.66 offering price on the first trading day.

The valuation is where the debate becomes serious. Goldman’s report reportedly had CXMT around 10x estimated 2027 earnings, while its CNY 129 target corresponds to roughly 24x 2027 earnings. In other words, reaching the target requires investors to pay a significantly higher multiple while simultaneously believing that earnings will expand rapidly. That makes execution and future DRAM pricing just as important as the headline capacity numbers.

The biggest structural risk is that memory remains cyclical. A strong DRAM environment can create exceptional profits, but aggressive capacity expansion across the industry can eventually change the supply-demand balance. If CXMT and other manufacturers add capacity faster than AI and server demand grows, memory prices could weaken and compress margins. This is particularly important because the current bullish semiconductor environment is already attracting substantial investment. Goldman itself expects China’s semiconductor capital expenditure to reach around $82 billion by 2030, highlighting both the opportunity and the potential for future oversupply.

Competition also cannot be ignored. Samsung, SK hynix and Micron remain the dominant global DRAM players, while CXMT is still developing its technology and scale. Counterpoint currently estimates Samsung at 39% of global DRAM revenue in Q2 2026, followed by SK hynix at 26% and Micron at 25%. CXMT's growth is impressive, but moving from rapid domestic expansion toward sustained global competitiveness will require continued improvement in process technology, yields and advanced-memory products.

The geopolitical angle strengthens the long-term narrative. China’s semiconductor strategy is increasingly focused on reducing dependence on overseas technology and building domestic supply chains. Goldman estimates China’s IC volume self-sufficiency rate reached about 70% by June 2026, up significantly from previous years. CXMT sits directly inside that strategic push because memory is a critical component across smartphones, servers, PCs and AI infrastructure.

For the market setup, the CNY 60–62 region is the first major technical checkpoint. CXMT has already experienced an extraordinary repricing since its IPO, so investors should distinguish between a fundamentally improving company and a stock that has already priced in a large amount of future growth. A sustained move through the recent highs with strong turnover would indicate that buyers are still willing to absorb elevated valuations. A rejection around the highs followed by a loss of the recent consolidation area would suggest that momentum is cooling and that the market needs to reset expectations.

Bullish scenario: CXMT maintains strong DRAM pricing, ramps capacity close to Goldman’s projections, improves yields, expands HBM production and continues gaining domestic market share. In that case, earnings estimates could keep moving higher and the CNY 129 target becomes increasingly defensible. The strongest confirmation would be rising revenue and margins alongside capacity growth, rather than price appreciation alone.

Bearish scenario: capacity ramps faster than demand, DRAM prices weaken, HBM development takes longer than expected or manufacturing yields disappoint. That would expose the gap between CXMT’s current valuation and its future earnings assumptions. Because the stock has already undergone an exceptional post-IPO repricing, disappointment could produce a much larger valuation reset than in a normal semiconductor name.

My read is bullish on the business trend but more cautious on the stock valuation. Goldman’s report gives CXMT a credible long-term growth framework: expanding capacity, AI-memory exposure, domestic substitution and a supportive DRAM cycle. But CNY 129 should be treated as an analyst scenario, not a guaranteed destination. The next stage of the story will be decided by actual production, pricing, HBM qualification, margins and cash-flow generation. If those numbers confirm the growth narrative, CXMT could become a serious global memory competitor; if they fail to keep pace with expectations, the market will quickly focus on valuation instead.

$CXMT ‌